Indications, technique, and safety profile of insular stereoelectroencephalography electrode implantation in medically intractable epilepsy
OBJECTIVE
Insular epilepsy is relatively rare; however, exploring the insular cortex when preoperative workup raises the suspicion of insular epilepsy is of paramount importance for accurate localization of the epileptogenic zone and achievement of seizure freedom. The authors review their clinical experience with stereoelectroencephalography (SEEG) electrode implantation in patients with medically intractable epilepsy and suspected insular involvement.
METHODS
A total of 198 consecutive cases in which patients underwent SEEG implantation with a total of 1556 electrodes between June 2009 and April 2013 were reviewed. The authors identified patients with suspected insular involvement based on seizure semiology, scalp EEG data, and preoperative imaging (MRI, PET, and SPECT or magnetoencephalography [MEG]). Patients with at least 1 insular electrode based on the postoperative 3D reconstruction of CT fused with the preoperative MRI were included.
RESULTS
One hundred thirty-five patients with suspected insular epilepsy underwent insular implantation of a total of 303 electrodes (1–6 insular electrodes per patient) with a total of 562 contacts. Two hundred sixty-eight electrodes (88.5%) were implanted orthogonally through the frontoparietal or temporal operculum (420 contacts). Thirty-five electrodes (11.5%) were implanted by means of an oblique trajectory either through a frontal or a parietal entry point (142 contacts). Nineteen patients (14.07%) had insular electrodes placed bilaterally. Twenty-three patients (17.04% of the insular implantation group and 11.6% of the whole SEEG cohort) were confirmed by SEEG to have ictal onset zones in the insula. None of the patients experienced any intracerebral hemorrhage related to the insular electrodes. After insular resection, 5 patients (33.3%) had Engel Class I outcomes, 6 patients (40%) had Engel Class II, 3 patients (20%) had Engel Class III, and 1 patient (6.66%) had Engel Class IV.
CONCLUSIONS
Insula exploration with stereotactically placed depth electrodes is a safe technique. Orthogonal electrodes are implanted when the hypothesis suggests opercular involvement; however, oblique electrodes allow a higher insular sampling rate.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Journal of Neurosurgery
5 publications, 11.11%
|
|
|
Child's Nervous System
4 publications, 8.89%
|
|
|
Operative Neurosurgery
3 publications, 6.67%
|
|
|
Frontiers in Neurology
3 publications, 6.67%
|
|
|
Epilepsia Open
3 publications, 6.67%
|
|
|
Brain Sciences
2 publications, 4.44%
|
|
|
Annals of Neurology
2 publications, 4.44%
|
|
|
Epilepsia
2 publications, 4.44%
|
|
|
Neurology: Clinical Practice
1 publication, 2.22%
|
|
|
Neurology
1 publication, 2.22%
|
|
|
Journal of Neurosurgery: Pediatrics
1 publication, 2.22%
|
|
|
Epilepsy Currents
1 publication, 2.22%
|
|
|
Zeitschrift fur Epileptologie
1 publication, 2.22%
|
|
|
Epilepsy Research
1 publication, 2.22%
|
|
|
Annals of Medicine and Surgery
1 publication, 2.22%
|
|
|
Seizure : the journal of the British Epilepsy Association
1 publication, 2.22%
|
|
|
Epilepsy and Behavior
1 publication, 2.22%
|
|
|
Neuromodulation
1 publication, 2.22%
|
|
|
Neuroscience Letters
1 publication, 2.22%
|
|
|
Surgical Neurology International
1 publication, 2.22%
|
|
|
Australasian Journal of Neuroscience
1 publication, 2.22%
|
|
|
Heliyon
1 publication, 2.22%
|
|
|
Therapeutic Advances in Chronic Disease
1 publication, 2.22%
|
|
|
Journal of Integrative Neuroscience
1 publication, 2.22%
|
|
|
Frontiers in Surgery
1 publication, 2.22%
|
|
|
International Journal of Biological Macromolecules
1 publication, 2.22%
|
|
|
Neurosurgical Review
1 publication, 2.22%
|
|
|
1
2
3
4
5
|
Publishers
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 publications, 17.78%
|
|
|
Wiley
8 publications, 17.78%
|
|
|
Springer Nature
7 publications, 15.56%
|
|
|
Journal of Neurosurgery Publishing Group (JNSPG)
6 publications, 13.33%
|
|
|
Frontiers Media S.A.
4 publications, 8.89%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
3 publications, 6.67%
|
|
|
Oxford University Press
3 publications, 6.67%
|
|
|
MDPI
2 publications, 4.44%
|
|
|
American Epilepsy Society
1 publication, 2.22%
|
|
|
Walter de Gruyter
1 publication, 2.22%
|
|
|
SAGE
1 publication, 2.22%
|
|
|
IMR Press
1 publication, 2.22%
|
|
|
1
2
3
4
5
6
7
8
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.